BY EU STUDIO

Wednesday, May 4, 2022-10:58

  • Share on Facebook

  • Share on Twitter

  • send by email

In Spain, gynecological cancer is the third most common cancer among women1.

Among gynecological tumors, endometrial cancer is the most common in Spain, followed by ovarian cancer and cervical cancer2.

Fortunately, despite the number of women diagnosed with these pathologies, mortality decreases in most cases.

Something that makes possible both the numerous advances in treatment and prevention measures and early diagnosis.


As part of the celebration of World Ovarian Cancer Day, on May 8, the "My name is Esperanza" campaign presents the "Camino a la Esperanza" initiative, a route created for Esperanza, a town in the municipality El Rosario on the island of Tenerife, for those women who have suffered or suffer from gynecological cancer.

A journey of improvement, friendship and companionship, which allows them to face their fears, reinforce their hope and set new goals and desires.

In short, a group walk of 21 km whose main destiny is to overcome adversity.

The result of this very special trip will be presented in September as part of World Gynecological Cancer Day.


"Overall cancer survival has, fortunately, doubled in the last 40 years. And this has been achieved thanks to the superb contribution and joint work of all health agents in the fight against cancer. And we are firmly convinced that evolution will continue hand in hand with continuing to work together", celebrates Eloy Gómez Palomo, vice president and director of the Oncohaematology area of ​​GSK in Spain.

With the aim of giving visibility, informing and supporting all women, family members and health professionals related to the disease, the 'My name is Hope' movement has emerged: a campaign made up of patients, oncologists, gynecologists and primary care doctors whose purpose is it is to give another color to the reality that patients live.

And that also highlights, during the difficult process of overcoming cancer, the relationship between doctor and patient, which is revealed as a key factor for the results.

This was demonstrated in the last colloquium carried out by GSK on 'Communication as Hope in the management of Cancer', a talk between the medical oncologist Elena García-Martínez and the patient Marisa Cots that confirmed the importance of this relationship, of the closeness and trust on both sides.

remain one

When a woman has just been diagnosed with gynecological cancer, confusion, lack of information and uncertainty hang over her.

And it is here where hope plays a fundamental role, since it can help her continue to be herself and make the path more bearable.

Beyond being a simple word, 'hope' has very valuable meanings.

From sentiment or attitude, to resilience and even a woman's name.

Everyone counts, everyone counts.

"Hope is what makes us go forward, face this stage and help our body and mind to respond better to the therapies we follow; to resume our daily chores, not overload our family environment and maintain a good quality of life. ", explains Charo Hierro, president of the Association of People Affected by Ovarian Cancer (ASACO), an entity that also supports the campaign.

In its commitment to supporting the knowledge and prevention of gynecological cancer, the GSK Oncohaematology unit works on continuous research, development and innovation, helping to transform the quality of life of affected women, turning cancer into hope.

Because the well-being of women tomorrow will depend on the progress we make today.

"At GSK we are driven by the commitment to change the reality of each cancer patient by supporting them through education, knowledge and prevention. Every day we strive to transform cancer into confidence, innovation and courage, so that people with cancer can do more, feel better and live longer. That is our purpose: to continue transforming cancer into Hope together", adds Eloy Gómez.

Pepa, Marian, José Antonio, Antonio or Ainhoa ​​are the names of some patients, relatives and medical professionals who are now accompanied by a middle name: Esperanza.

"A name that can change the fate of gynecological cancer," says the GSK campaign, which also has the support of the Hereditary Mama Ovary Association (AMOH), the Association of People Affected by Ovarian Cancer (ASACO) and the Spanish Group of Ovarian Cancer Research (GEICO).

Reference:1.

European Cancer Information System (ECIS).

Estimates of cancer and mortality in 2020, for all cancer sites [Internet].

2020. [Last access: March 2022].

Available at: https://gco.iarc.fr/today/online-analysis-table?v=2020&mode=cancer&mode_population=continents&population=900&populations=724&key=asr&sex=2&cancer=39&type=0&sta-tistic=5&prevalence=0&population_group=0&ages_group%5B %5D=0&ages_group%5B%5D=17&group_cancer=1&include_nmsc=0&include_nmsc_other=1#collapse-group-0-42.

Spanish Society of Medical Oncology (SEOM).

Cancer figures in Spain.

2022. Available at: https://seom.org/images/LAS_CIFRAS_DEL_CANCER_EN_ESPANA_2022.pdf.


NP-ES-AOU-PINS-220017(v1)05/2022


For more information, ask your doctor

Made by UE Studio

This text has been developed by UE Studio, a creative branded content and content marketing firm from Unidad Editorial, for GSK.

Conforms to The Trust Project criteria

Know more